Trump: DOJ considering 'major litigation' against opioid companies

President Donald Trump on March 19 reaffirmed the possibility of a federal lawsuit spearheaded by the Department of Justice against drug companies for their alleged role in facilitating the nation's opioid crisis, according to a report from STAT.

President Trump made the comments during a speech in New Hampshire to introduce the White House's strategy to address the opioid crisis. President Trump previously mentioned a potential federal lawsuit against drug companies March 1. This time, the president was more forceful with his comments, describing the potential legal action as "major."

"Our Department of Justice is looking very seriously into bringing major litigation against some of these drug companies," said President Trump, according to STAT. "We will bring it at a federal level. Some states are already bringing it, but we are thinking about bringing it at a very high federal level, and we will do a job."

States, cities and local governments nationwide have filed hundreds of lawsuits in recent months against drug companies for allegedly engaging in deceptive marketing tactics to promote widespread, unsafe use of opioid medications. On Feb. 27, Attorney General Jeff Sessions announced the formation of a DOJ task force to increase scrutiny on opioid manufacturers and distributors. The task force was also charged with examining local and state opioid epidemic lawsuits to determine what assistance federal law could provide to these legal actions.

To read the full STAT report, click here.

More articles on opioids: 
Medicaid essential to addressing opioid epidemic: 4 report insights 
Death penalty, media campaigns and more: 5 things to know about Trump's opioid plan 
South Dakota sues drugmakers over opioid marketing practices

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers